As a Senior Program Manager, Global Quality IT Platforms, you will lead large-scale Quality IT initiatives that support Fresenius Kabi’s highly regulated pharmaceutical business. You will shape global Quality platforms that underpin product quality, regulatory compliance, and operational excellence.
Working with senior business and IT executives, global stakeholders, and cross-functional teams, you will manage strategic programs from planning through implementation and release across multiple regions.
Your responsibilities:
Lead complex global Quality IT programs and platform transformations from strategy through release.
Govern the full delivery lifecycle: planning, requirements, risk management, testing, and deployment.
Advise senior business and IT executives to inform decisions and shape future Quality capabilities.
Manage program budgets, global stakeholders, and cross-functional teams across multiple regions.
Ensure compliance with GxP requirements while balancing innovation, efficiency, and business value.
Lead steering committees and engage executive stakeholders at VP and senior management level.
Your qualifications:
10+ years of experience leading large-scale IT programs in pharmaceutical, life sciences, or other regulated GxP environments.
Strong expertise in Quality Management Systems such as Veeva, IQVIA, or TrackWise and in digital transformation initiatives.
Proven program and project management experience; PMP, PRINCE2, or an equivalent qualification is preferred.
Deep understanding of IT service management, governance, and release management practices.
Ability to lead global teams and communicate effectively with stakeholders across complex international organizations.
Ability to navigate complexity, influence executive decisions, and deliver strategic business outcomes.
Fluent English and willingness to travel internationally when required.
Drive the future of Fresenius Kabi — join #futurefresenius and apply now through our online portal to make an impact!
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.
User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: www.fresenius-kabi.com/imprint
